• Guggenheim upgraded NASDAQ:NEOG to a "Buy" rating with a new price target of $12, leading to a significant stock price increase.
• Despite a year-over-year revenue decline to $224.7 million and a slight drop in non-GAAP net income to $22.6 million, Neogen exceeded analyst expectations.
• The company's stock experienced a 31.57% increase, attributed to outperforming market predictions despite revenue declines from divestitures and discontinued product lines.

Neogen Corporation, trading on the NASDAQ under the symbol NEOG, is a company that specializes in food and animal safety products. On January 9, 2026, Guggenheim upgraded NASDAQ:NEOG to a "Buy" rating, setting a new price target of $12, up from $8. At the time, the stock was priced at $9.71.

Following the release of its fiscal second-quarter earnings report, Neogen's stock surged by over 31%. Despite a nearly 3% year-over-year decline in revenue to $224.7 million and a slight drop in non-GAAP net income to $22.6 million, the company exceeded analyst expectations. Analysts had anticipated revenue just above $208 million and non-GAAP net income of only $0.03 per share.

Neogen attributed the revenue decline to divestitures and discontinued product lines. However, the company's ability to outperform market predictions led to a positive response from investors, driving the stock's significant increase. The stock, currently priced at $9.71, has experienced a rise of $2.33, marking a 31.57% increase.

Today, NASDAQ:NEOG's stock has fluctuated between a low of $9.12 and a high of $10.24. Over the past year, the stock has reached a high of $12.98 and a low of $3.87. Neogen's market capitalization stands at approximately $2.11 billion, with a trading volume of 22.68 million shares.